Rahul Sharma, MD
Interventional Cardiology · Stanford, CANPI 1548735509
Payments from drug & device makers
Across 2,050 payments — averaging $3212.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$5.3M
- Boston Scientific$546K
- Abbott$280K
- Cathworks, Inc.$257K
- Siemens Medical Solutions USA, Inc.$44K
- Shockwave Medical, Inc$40K
- plus $85K from 21 others
Across 1 payment — averaging $4950.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$5K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 1,301 | $5,332,469 |
| Boston Scientific | 174 | $545,956 |
| Abbott | 235 | $279,555 |
| Cathworks, Inc. | 51 | $257,239 |
| Siemens Medical Solutions USA, Inc. | 21 | $44,456 |
| Shockwave Medical, Inc | 74 | $40,174 |
| Biosense Webster, Inc. | 2 | $21,402 |
| Medtronic(2 entities) | 90 | $19,935 |
| Philips North America LLC | 55 | $18,092 |
| Cardiva Medical, Inc. | 13 | $14,769 |
| Opsens Inc. | 7 | $8,041 |
| Cvrx, Inc. | 9 | $1,270 |
| Merz North America, Inc. | 1 | $261 |
| Biotronik Inc. | 2 | $191 |
| Viz.ai, Inc. | 1 | $183 |
| Penumbra, Inc. | 1 | $156 |
| Terumo Medical Corporation | 1 | $142 |
| W. L. Gore & Associates, Inc. | 3 | $136 |
| Abiomed | 1 | $92 |
| Atricure, Inc. | 1 | $52 |
| Teleflex LLC | 1 | $42 |
| Asahi Intecc USA, Inc. | 1 | $36 |
| Cardiac Dimensions, Inc. | 1 | $32 |
| Jenavalve Technology, Inc. | 1 | $26 |
| Angiodynamics, Inc. | 1 | $22 |
| AstraZeneca | 1 | $19 |
| Lupin Inc. | 1 | $13 |
How this compares
$6,584,762 in reported general payments places this provider in the 95th percentile of 585 interventional cardiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Stanford
- David LeeStanford$5.7M
- William FearonStanford$3.7M
- Jennifer TremmelStanford$835K
- Todd BrintonStanford$279K
- Rajendra MakkarWest Hollywood$16.6M
- Fahed BitarCovina$9.9M
- Matthew Pricela Jolla$5.8M
- Saibal KarThousand Oaks$5.4M
- Mehrdad ArianiNorthridge$5M
- Frederick St GoarMountain View$4.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.